Top Markets
#1 ADO Protocol ADO Protocol +192.94%
#2 Islamic Coin Islamic Coin +155.28%
#3 GoPlus Security GoPlus Security +49.48%
#4 GAIB AID GAIB AID +24.67%
#5 Starpower Starpower +24.23%
#6 Verus Coin Verus Coin +13.55%
#7 o1.exchange o1.exchange +13.37%
#8 Casper Network Casper Network +12.96%
#9 SkyAI SkyAI +11.53%
#10 Pons Pons +10.30%
Coin of the day
ADO Protocol ADO Protocol
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

CUPR
Rang in aandelen #33376
Cuprina Holdings (Cayman) Limited is a Singaporean biotechnology and biomedical... Cuprina Holdings (Cayman) Limited is a Singaporean biotechnology and biomedical enterprise, primarily dedicated to pioneering and bringing to market advanced solutions for the management of persistent wounds. The company produces and supplies its flagship MEDIFLY brand, which features medical-grade sterile blowfly larvae bio-dressing products designed to function as an effective biological debridement tool for chronic wounds. Beyond its core wound care business, Cuprina also extends its operations into the broader health and beauty market, where it provides a range of cosmeceutical items.
Aandeelprijs
$2.90
Laatst gesynchroniseerd: 2026-08-14
Marktkapitalisatie
$7.78M
Verandering (1 dag)
-6.45%
Verandering (1 jaar)
-69.54%
Land
SG
Handel Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)

Categorie

Healthcare
P/S-ratio voor Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)
P/S-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van Cuprina Holdings (Cayman) Limited Class A Ordinary Shares is de huidige P/S-ratio (TTM) 0. Eind 2026 had het bedrijf een P/S-ratio van 0.
P/S-ratiohistoriek voor Cuprina Holdings (Cayman) Limited Class A Ordinary Shares van 2026 tot 2026
P/S-ratio aan het einde van elk jaar
Jaar P/S-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/S-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/S-ratio Verschil in P/S-ratio Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE